Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.43 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.43 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.43 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11125832 | 0.84 | PRKCA (0.38) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL3222443 | 0.83 | PRKCA (0.67) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL640917 | 0.83 | PRKCA (0.46) | PRKCAPRKCEPRKCQPRKCDCA1 | |
| SCHEMBL5495059 | 0.83 | PRKCA (0.46) | PRKCAPRKCEPRKCQPRKCDCA1 | |
| SCHEMBL10632353 | 0.81 | CA1 (0.40) | PRKCAPRKCEPRKCQPRKCDCA1 | |
| SCHEMBL6834592 | 0.79 | CA1 (0.39) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL21662508 | 0.79 | CA1 (0.39) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL460712 | 0.79 | TDP1 (0.39) | ALDH1A1CA1CA2CA7TSHR | |
| SCHEMBL1862658 | 0.79 | TSHR (0.37) | PRKCAPRKCEPRKCQPRKCDCA1 | |
| SCHEMBL9508419 | 0.78 | CA1 (0.38) | PRKCAPRKCEPRKCQPRKCDCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4595681-A | Administering neutral glycerolipid | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1986-06-17 | — | — | US | claimed |
| US-4595681-A | Administering neutral glycerolipid | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1986-06-17 | — | — | US | disclosed |